IRP Tool is not optimized for mobile devices.
Please visit using a desktop device!
IRP Logo

The Investment Readiness Process
by BEELS®

IRP Report

The Investment Readiness Process by Beels® help founders and investors to more efficiently agree how the company contributes to meeting both parties' goals and expectations. This IRP Report is produced by the founders to describe the company’s goals, plans, risks and potential return for investors.

21 May 2025

Healplay

Image 2

Meet the Team


Quick Facts

Global Goal focus

  • Goal 3. Good health and well-being
  • 3.4
  • 3.8
  • Goal 8. Decent work and economic growth
  • 8.2
  • 8.4
  • Goal 11. Sustainable cities and communities
  • 11.3
  • Goal 12. Responsable consumption and production
  • 12.5
  • 12.6
  • 13.2

Mega Trends

  • Climate change and resource scarcity
  • Demographics and social change
  • Technological Breakthrough

Industry

  • AI
  • HealthTech
  • MedTech

Business Model

  • B2C – Business to consumer
  • B2B – Business to business

Pitch deck

We share our pitch with you (available as a download in the digital report) and hope you find our company interesting.

Download Pitch

Heal Play Pitch Open pdf

Interview with the founders

1. What are you working on? (1.1 What does that give to a customer?, 1.2. And what does that give, 1.3 How will it contribute to the world?)

Image 2

1. HealPlay is an innovative business, that is responding to the growing demand for a modernized approach to physiotherapy. It aims to revolutionize the traditional physiotherapy methods by integrating AI and 3D Body Pose technology together with sensor capabilities in the mobile phone. The core of HealPlay's product is a dual-component system: a patient app for prevention and rehabilitation, and a healthcare professional app and platform for efficient management of medical follow-ups, data analytics, and administrative tasks. This solution promises to facilitate remote physiotherapy sessions and video calls, thereby minimizing travel requirements, reducing carbon emissions, and encouraging patients to complete their treatment plans. HealPlay aspires to enhance the accessibility of physiotherapy services, improve the allocation of HCP resources, and elevate the overall standard of healthcare delivery. 1.1 The HealPlay app is designed to revolutionize physiotherapy by providing a user-friendly and engaging platform for patients. Upon logging in, patients complete an anamnesis of pain- and health issues to inform the creation of a personalized exercise program, tailored by a physiotherapist with their own AI assistant. The app's innovative use of AI, along with 3D body pose and tracking technology, enables an interactive digital coach to guide patients through their exercises on their mobile phones. Real-time visual and voice feedback ensures that patients perform their exercises correctly, with the app's adaptability catering to individual health conditions and preferences. Data collection and analysis offer valuable insights for both patients and therapists, enhancing the therapeutic process. Gamification elements like progress meters and competitions, along with rewards and discounts, serve to motivate patients, making the rehabilitation journey more enjoyable and effective. Additionally, the ability to rate their experience and physiotherapist adds a layer of interaction and satisfaction for users. HealPlay is poised to revolutionize the Swedish health sector with its innovative app designed for healthcare professionals (HCPs). This cutting-edge tool stands out for simplifying patient data collection and enhances the management of prevention and rehabilitation services. By integrating real-time data from a patient app, physiotherapists gain valuable insights into patient exercise movements and treatment progress. This enables them to tailor treatments and programs more effectively, ensuring exercises are performed correctly and treatment plans are completed satisfactorily. HealPlay's commitment to "ease of use" and its advanced AI/machine learning applications are set to make it a frontrunner in the market, surpassing international competitors and instilling confidence in both patient users and HCPs regarding the quality of rehabilitation exercises. 1.2 and 1.3 HealPlay's solution will enable digital appointments (video calls) and physiotherapy sessions at home, reducing the need for travel (lower carbon emissions) and centralizing/simplifying patient administration processes. Physiotherapy and increased physical activity improve recovery and reduce long-term sequelae of a previous injury and other health complications. Also, a complete and speedy recovery contributes to increased productivity, reduced sick leave, and optimizes the use of healthcare resources. Ultimately improving patients' quality of life. Problem: However, more than 50% of the patients do not complete their program nor meet their goals. Also, healthcare professionals (HCP) can't access and analyze patients' physiotherapy data to follow-up and make changes on a one-on-one need basis. Being able to assess if the patient is performing movements correctly and progressing in their respective program is neither possible. Also, patients find it difficult to understand instructions and lack the interest and motivation to carry out their training and finish their prevention/rehab program. Physical inactivity and the occurrence of high BMI is estimated to cost EUR 2.5 billion a year (WHO).

2. Why are you (individually) doing this? (2.1 What is your goal? 2.2 Do you have a financial goal? 2.3 When do you need to reach that goal? 2.4 What is the goal behind that goal?)

Image 2

2. In 2020, I (Anna Unander) was on sick leave due to pelvic pain when pregnant with her first child (Vera). My muscles had shortened due to the added weight gained during pregnancy, resulting in frequent cramps. I sought physiotherapy at a clinic where a physiotherapist showed me some exercises live and gave me the exercise instructions on a paper. I found the instructions difficult to understand and the program unmotivating to complete. My own experience triggered HealPlay’s search for a seamless, user-friendly, interactive, comprehensive, knowledge-based, and motivating solution to the above mentioned problem. What more inspired me to become an entrepreneur is to be able to build something from the ground up from just an idea, to be able to create something real, to be able to influence and do good for society, to be able to decide on my own time and commitment and to be able to choose who I want work with. 2.1 I intend to make HealPlay the first digital tool in Sweden that uses AI motion tracking and sensor technology in the phone in rehabilitation and prevention. Vision: "To create a playful, motivating and accurate healing journey." Mission: "To make healthcare accessible, provide a pain-free life in mobility and maximize quality of life with rehabilitative and preventive care services for patients." HealPlay's business objectives are strategically aligned with enhancing patient health outcomes and operational efficiency. The goals are to: 1. Utilize HealPlay's products to improve patient mobility and reduce associated healthcare and social costs. 2. Boost patient engagement and consistency in following prescribed exercise and rehabilitation programs. 3. Establish HealPlay as the go-to tool for physiotherapists. 4. Stimulate economic growth by creating employment opportunities and generating revenue. 5. Monitor and contribute positively to societal and environmental sustainability. To ensure these objectives are met, HealPlay plans to implement a comprehensive follow-up strategy that includes: 1. Conducting clinical studies and cost analyses to evaluate the health and social impact of their products on variables such as pain, mental health, surgical needs, medication usage, absenteeism, productivity, and overall quality of life. 2. Developing automated systems to track patient adherence to rehabilitation and Prevention as Prescription (PaP) programs. 3. Leveraging real-time data tracking of patient progress, supplemented by Patient-Reported Outcome Measures (PROMs) and in-depth interviews to gain insights into the efficacy of training programs. 4. Performing financial analyses and reviewing annual financial statements to assess revenue growth, job creation, and profitability. 5. Measuring social and sustainability impacts against international standards and frameworks, such as the Sustainable Development Goals (SDGs), UN Global Compact, Iris+, and the Principles for Responsible Investment (PRI) by the International Finance Corporation (IFC). This structured approach aims to not only foster a robust business model but also to contribute meaningfully to the well-being of patients and the broader community. 2.2 and 2.3 The Swedish domestic market for physiotherapy services presents a significant opportunity for digital healthcare providers. The Total Attainable Market (TAM) is valued at SEK 2475 million, based on the 9 million appointments recorded in 2019 and the recommended compensation of SEK 275 per digital appointment by SALAR. The Service Attainable Market (SAM), which represents the portion of TAM that can be delivered digitally, is projected to be worth SEK 1238 million annually, assuming that 50% of primary care physiotherapy and occupational therapy appointments transition to digital platforms within five years. For HealPlay, aiming to become a leader in digital rehabilitation and prevention solutions, the Service Obtainable Market (SOM) could reach SEK 248 million annually by capturing 20% of the SAM within three years. With ambitions to double this market share to 40% within six years, the potential annual SOM could grow to SEK 495 million. On an international scale, the physiotherapy service market is even more substantial, with a TAM of USD 166 billion as of the last 2018 study. If the trend towards digital appointments continues and reaches 50% of the market, the international SAM could be valued at USD 83 billion. For HealPlay aims to take 20% of the global SAM market, amounting to USD 16,6 billion, to become a leading digital solution for rehabilitation and prevention. This global shift towards digital healthcare opens up expansive prospects for companies like HealPlay to tap into a growing demand for remote physiotherapy services. The figures suggest a robust growth trajectory for digital healthcare solutions in both domestic and international markets. 2.4 To become a leading digital solution for rehabilitation and prevention.

3. Why now? (3.1 Why will this succeed now?)

Image 2

3. 3.1 The COVID-19 pandemic has significantly accelerated the adoption of digital healthcare solutions, reshaping the landscape of medical care delivery. The integration of technology in healthcare, particularly through telehealth services, has enabled clinicians to provide uninterrupted care while adhering to social distancing measures. The statistics highlights a substantial shift in the healthcare industry, with a vast majority of clinicians (96%) now utilizing telehealth platforms during the pandemic. This transition not only ensured patient safety but also maintained the continuity of care during unprecedented times. Moreover, the inclination of 91% of clinicians to continue using technology post-pandemic suggests a long-term transformation in healthcare practices. Innovations in computer vision and consumer technology have played a pivotal role in this shift, enabling remote patient monitoring and diagnostics, thus reducing the need for physical consultations. These advancements have not only facilitated patient access to medical care but have also streamlined the process for healthcare providers. The move towards remote care has also opened up new avenues for technology innovation within the healthcare sector. It has spurred the development of more sophisticated and user-friendly telehealth platforms, wearable health monitoring devices, and AI-driven diagnostic tools. These technologies are poised to enhance patient engagement, improve health outcomes, and reduce healthcare costs in the long run. Overall, the pandemic has acted as a catalyst for the digital transformation of healthcare, with technology innovation at its core. The continued use of these digital health solutions is likely to become an integral part of the 'new normal' in medical care, long after the pandemic has subsided.https://healthcareglobal.com/telehealth-and-covid-19/transforming-mental-health-with-digital-healthcare-in-2022

4. What is you unfair competitive advantage? (4.1 Something that no-one else have?)

Image 2

4. HealPlay's Comparative Advantage in the Domestic and International Markets Domestic Market (Sweden): HealPlay stands out in the Swedish market by offering a solution that integrates real-time coaching with video conferencing capabilities, allowing patients to communicate directly with physiotherapists. Unlike existing solutions that rely solely on instructional videos, HealPlay utilizes sensor tracking to monitor and provide immediate feedback on patients' movements, ensuring exercises are performed correctly. This technology surpasses the current market offerings, which at best, provide only a static overview of patient progress without the means to collect and analyze data comprehensively. International Market (Global): Globally, while motion tracking technology is available, it often presents as a lackluster experience with a basic user interface and limited AI feedback. These solutions typically require additional equipment to be worn by the patient, which can be costly and environmentally unfriendly. Furthermore, they lack the incorporation of gamification strategies that could motivate and engage patients throughout their treatment programs. Additionally, the international offerings are predominantly English-based and do not adhere to the specific public health regulations of Sweden or other non-English speaking countries. 4.1 HealPlay's Comparative Advantages: 1. No Additional Devices Required: HealPlay eliminates the need for patients to purchase and wear external sensors, setting it apart from competitors like Hinge Health and Sword Health. This not only reduces expenses but also aligns with a more sustainable and environmentally conscious approach. 2. Interactive Experience: Unlike its competitors, HealPlay offers a unique, interactive 3D body pose experience and gamification elements, enhancing patient engagement and potentially improving treatment adherence and outcomes. In conclusion, HealPlay's innovative approach to physiotherapy solutions offers significant advantages over existing domestic and international products. By focusing on real-time interaction, comprehensive data analysis, and an engaging user experience, HealPlay is poised to revolutionize the way physiotherapy is delivered and experienced by patients worldwide.

5. Describe your competitors?

Image 2

In the Swedish market, the potential competitors are: - Joint Academy - Rehabilitation focuses on mainly arthrosis (MSK) - Healo - Physical therapy and occupational therapy - Physiapp - Physical therapy and occupational therapy - Vitala – Prevention (Physical Activity on Prescription) - Habbie - Physical therapy, occupational therapy and Prevention There are no similar solutions on the Swedish market today. The available solutions offer only instructional videos or mirroring without real-time coaching and video conference capabilities to communicate patients with physiotherapists. Those solutions lack tracking and data technology and cannot monitor patients' movements nor provide them with feedback/coaching in real-time to do the exercises (treatment) correctly. Patients can only use surveys to give their opinion on customer service and satisfaction with the service (i.e., video conferencing technology and healthcare professionals). At most, those solutions only provide a snapshot of the progress/data made by the patient and are lack the ability to collect and analyze patient data. In the international market, the competitors are: • Kaia Health - rehab for patients with MSK disease • Hinge Health - rehab for patients with MSK disease • Sword Health - rehab for joint and muscle pain Internationally, motion tracking or motion sensor technology exists, but often in the form of a dull, empty user interface with only a joint skeleton to mimic a patient's movements with an AI feedback voice. The AI feedback voice is limited to a few simple commands and requires the use of extra equipment (devices) attached to the patient body. Also, those solutions have not integrated gamification as a strategy to monitor, encourage and motivate patients to continue training and complete their treatment program. International solutions are not available or only available in English and are not compliant with the Swedish public health rules and regulations to work. The same issue applies for other countries and languages.

6. How do you make money?

Image 2

HealPlay is leveraging a multi-faceted revenue model to monetize its services and offerings in the physiotherapy and wellness space. Here’s how we are generating income: Subscription Plans: Premium Membership: This is the core revenue stream where users pay for advanced features, personalized programs, and exclusive content. This adds significant value for users seeking a more tailored experience. Patient Subscription Plans: Patients can choose from a variety of subscription options, which provide access to a range of physiotherapy programs and targeted exercises. Each plan includes unique benefits, enhancing the value proposition for patients. Physiotherapist Subscription Plans: These plans are designed for physiotherapists and include features that allow them to manage their patients’ therapy sessions, receive live feedback, and access data insights on patient exercises. It also helps them attract new users by enabling them to create specialized programs. Consultation Fees: HealPlay offers paid personal consultations with professional physiotherapists, allowing for the creation of customized care plans for individual needs. Corporate Partnerships: Corporate Wellness Programs: By partnering with corporations, HealPlay provides physiotherapy resources as part of corporate wellness initiatives, promoting overall employee health. Sponsored Content and Advertising: The platform hosts sponsored content and advertisements from relevant healthcare and physiotherapy equipment brands, creating an additional revenue channel. Affiliate Marketing: HealPlay earns commissions through affiliate marketing, promoting physiotherapy, wellness, and healthcare products. In-App Purchases: Users can opt for program add-ons, such as advanced workouts, meditation sessions, and diet plans, enhancing their personalized experience. Data Analytics: The company licenses anonymized data insights to entities in the healthcare, research, and insurance sectors, providing valuable information while respecting user privacy. HealPlay is not only ensuring a steady flow of income but also fostering a comprehensive ecosystem that benefits patients, physiotherapists, and the broader healthcare community therapy for prevention and rehabilitation purposes will be HealPlay’s primary users.

7. How do you charge customers?

Image 2

Subscription Plans (main revenue option) 1 and 2: Premium Membership: Subscriptions for advanced features, personalized programs and exclusive content for user value. 1) Patient Subscription Plans: Various subscription plans are available for patients, granting them access to publicly available physiotherapy programs and targeted exercises. These plans also include additional benefits specific to each HealPlay plan. 2) Physiotherapist Subscription Plans: Different subscription plans are offered for physiotherapists, allowing them to onboard their patients for planned physiotherapy sessions, get extended live feedback or data instates of there patients exercises. Additionally, these plans connect new users seeking physiotherapy by creating specialized programs as part of their subscription. Consultation Fees: Offering paid personal consultations with professional specialized physiotherapists for customized care plans. Corporate Partnerships: Corporate Wellness Programs: Corporate wellness by offering physiotherapy resources, fostering employee health, through corporate subscriptions. Sponsored Content: Sponsored content and ads (recommendations) from healthcare and physiotherapy equipment brands. Affiliate Marketing: Affiliate commissions on physiotherapy, wellness, and healthcare products. In app purchase: Program Add-Ons: Optional premium features like advanced workouts, meditation, and diet plans for a personalized experience. Data analytics: Data Insights: Anonymized data insights licensing to healthcare, research, and insurance sectors. ______________________________________________________________ In the future, B2G: The region reimburses rehabilitation (SEK 275 per visit/approx. 10). Rehabilitation is financed by the regions in accordance with the national agreement for non-county compensation for digital care of SEK 275 (price level recommended by SALAR).

8. How much does an average customer spend per year? (8.1 Or, how much will an average customer spend per year?)

Image 2

Given: - Average monthly spending per user: 450 SEK Calculation: - Annual spending per user = 450 SEK/month * 12 months/year So, on average, a customer can spend 5400 SEK per year. Twenty physiotherapists affiliated with HealPlay would be needed to sell 68,177 digital appointments. That number of digital appointments represents only 1.5% of the estimated service attainable market - SAM in Sweden. HealPlay aims to capture 20% of SAM in Sweden within three years.

9. Give three top reasons why this will fail?

Image 2

1. Regulatory Challenges: Health tech startups must navigate complex and stringent regulations. Non-compliance can lead to legal issues and shutdowns. The healthcare industry is subject to stringent regulations. Any changes in privacy laws or reimbursement policies could impact HealPlay’s operations, especially the planned B2G revenue stream. Mitigation: Hire or consult with legal experts specializing in health tech regulations to ensure compliance. Stay updated on changes in regulations and incorporate compliance into the development and operational processes. 2. Funding Challenges: Sustaining operations and growth in the health tech industry typically requires significant funding. Difficulty in securing or maintaining investment can lead to financial strain. Mitigation: Develop a solid business plan and maintain transparent financial practices to attract and retain investors. Explore diverse funding sources, such as venture capital, angel investors, grants, and crowdfunding. 3. Partnerships and Network: Building and maintaining partnerships with healthcare providers, physiotherapists, and other stakeholders are crucial. Poor network and collaboration can limit growth and reach. Mitigation: Build and maintain strong relationships with healthcare providers, physiotherapists, and other stakeholders. Offer mutual benefits and create collaborative programs to ensure long-term partnerships. Attend industry events and actively network to expand connections.

10. What does an exit look like?

Image 2

A buy out from KRY or Plattform24. The former Director of Product at Kry Sweden- Livi Hoa Ly, says that KRY would be interested in having HealPlay's finished products in Kry’s platform. It will be based on how easy it will be to integrate HealPlay's products in Kry’s platform and the possibility of showing future traction.


What will drive long term value?

What drives value in our future company? We call them "value driving factors". They are factors that help the company to achieve the turnover and profit targets we have set as goals to be achieved in our ”normal case”.

This is what makes the company value grow and hopefully make it possible for our now coming investors to exit their shares with a profit.

Planned year of exit for first investor

2029

To reach our long term ”Normal case” goals we have set targets (milestones) that reflect a realistic progression on each selected Value-driving factor from Start of our plan to the year when we plan for our now coming investors to exit their investment.

Impact/ESG At start
Aug 2024
At 6 months
Mar 2025
At 40%
Oct 2026
At exit
Dec 2029
SDG13 - CO2 reduction Digital physiotherapy reduces physical visits/travel and CO2 emissions 0 visits/year = 0 C02 savings 70 000 visits/year = 72 ton C02 savings 900 000 visits/year = 914 ton CO2 savings 3.375 M visits/ year = 3.375 ton CO2 savings.
SDG3.8 - Access to Physiotherapy healthcare service Access to physiotherapy care in Sweden regardless of where they live or gender (90% success rate). 0 people 6300 people 81 000 people 160 000 people (10 visits/person of 1,8 M visits)
SDG3 - Good Health and wellbeing Clinical study - Reduced pain 0% 40% 60% 80%
SDG3 - Good Health and wellbeing Clinical study - Reduced depression and anxiety 0% 30% 50% 70%
Sales/Market/Customer At start
Aug 2024
At 6 months
Mar 2025
At 40%
Oct 2026
At exit
Dec 2029
External Market share 20% - in 10 years SAM: estimated at USD 83 billion (SEK 829 billion per year, assuming 50% can be treated digitally 0% 2% (17 B SEK) 10% (82 B SEK) 10% (83 B SEK)
Internal Market share (*Sweden) Market share. Annual SAM market value of SEK 495 million. 0% 2% (9,9 M SEK) 20% (99 M SEK) 20% market 900 K visits - 22 M Euros (247.5 M SEK)
Product/Technology/Business Model At start
Aug 2024
At 6 months
Mar 2025
At 40%
Oct 2026
At exit
Dec 2029
Calculate patients' adherence to rehabilitation and PaP programs automatically from real-time data (follows the patient) as well as PROM assessment and interviews 0% 50% 70% 90%
Number of digital appointments Break even is 68 177 digital appointments 0 70 000 900 000 1 800 000
Growth rate digital visits - year 2026 Expected growth, coming years: Source SALAR, digital physio market (SAM) in Sweden is 4,5 M visits 0% SAM 1,5% SAM 20% SAM 40% SAM
Assets/Team/IPR At start
Aug 2024
At 6 months
Mar 2025
At 40%
Oct 2026
At exit
Dec 2029
MVP - Software with video library Excluded live mocap feedback/AI MVP Patient app (for Google Play) - video playback and 3D motion capture environment MVP Physiotherapist interface. Build on IOS(App Store done Tested and launched products MVP with video library in August 2024
ML/AI algorithm prototype Image recognition, pose detection, motion capture ML/AI tools exploration (starting with Google ML Kits) Vital components of pose detection and motion capture done ML/AI algorithm and models for pose detection and motion capture well functioning 3D Body pose vision in app
Gamification principals Gamification - includes: progress meter, sharing of results as well as virtual gifts and Heal Points Decide on principals Build done Well working gamification principals Implemented: HealPoints, Badges, Goals & feedback
Copyright of data and videos Training videos, 3D pose data, instructional videos, coaching instructions Plan for IP rights Standard process set on how to copyright IP (videos and 3D data that HealPlay produces) IP Copyright of 3D data (videos, animations and environments) Has ownership and compliance of all video and data
Medical Product Certification - CE Marking CE Marking Regulatory roadmap for CE marking that is needed Contacting CRO organization/external QA experts CE Marking for Medical Product CE Marking for MDR
Expert Development Team Team dedicated to creating high-quality and impactful features Initial team of key developers in place. Fully staffed and operational team. Consistent quarterly feature updates. Stable team with high productivity

How will we use the funds?

In order to reach our milestone we have made a roadmap from start of plan to the year of we plan for our now coming investors to exit their investment. This roadmap shows key activities in each area of the company, that need to be completed by a certain point in time in order for the company to achieve the goals for each Milestone.

The strategic roadmap is divided in three parts where the first plan, on a monthly basis, shows how we will reach the first milestones in 6 months from start of plan. The second part is a quarterly plan and the last part is a yearly plan.

CE Marking

Legal/Regulatory

IP and patent

Clinical (R&D)

Marketing and PR

Organization

Sales

Financing and fundraising

Accounting

Sustainability

Tech/Service/Product

2024
Sep
Deter­mine Clas­si­fi­ca­tion: Assess whether the app falls under the def­i­n­i­tion of a med­ical device
Con­sult­ing with a reg­u­la­to­ry expert or cer­ti­fi­ca­tion body to ensure compliance
Data Pri­va­cy and Pro­tec­tion: Adhere to data pri­va­cy laws such as GDPR and patient data act in Europe, espe­cial­ly con­cern­ing patient data used by the AI for ana­lyt­ics and follow-ups
Licens­ing and Cre­den­tial­ing: Ver­i­fy that all health­care pro­fes­sion­als (phys­io­ther­a­pists) using the HealPlay are prop­er­ly ver­i­fied (licensed and cre­den­tialed), when pro­vid­ing dig­i­tal health services
Trade­mark Reg­is­tra­tion: Secure trade­marks for the HealPlay brand, includ­ing the name and any unique logos or designs asso­ci­at­ed with the apps to estab­lish a strong brand iden­ti­ty in the market
Con­sult with IP legal pro­fes­sion­als to tai­lor roadmap and actions
Phase 1: Brand Iden­ti­ty and Posi­tion­ing — Devel­op a strong brand iden­ti­ty that res­onates with the core val­ues of inno­va­tion, acces­si­bil­i­ty, and sustainability.
Hire CMO- co-founder: Chief mar­ket­ing and sales
Hire Tobias from Karolin­s­ka Insti­tutet, lead Phys­io­ther­a­pist: To ensure clin­i­cal rel­e­vance and guide prod­uct design.
Con­tin­ue use UX/UI Design­er (Anna Stam) in team: To ensure a user-friend­ly expe­ri­ence in both apps.
Phase 1: Mar­ket Analy­sis deep dive and Strat­e­gy Devel­op­ment — Con­duct com­pre­hen­sive mar­ket research to iden­ti­fy tar­get demo­graph­ics and mar­ket needs
Phase 1: Seed Cap­i­tal — Objec­tive: Secure ini­tial fund­ing to final­ize prod­uct devel­op­ment and launch pilot programs.
- Devel­op a detailed busi­ness plan out­lin­ing the mar­ket oppor­tu­ni­ty, busi­ness mod­el, and rev­enue projections.
- Explore gov­ern­ment grants and sub­si­dies for health­care inno­va­tion and tech­nol­o­gy development.
Final­ize team recruit­ment process.
Onboard new developers
Set up devel­op­ment tools and environment
Con­tin­ue Feed­back and CICD on cur­rent MVP build APP
Oct
Con­for­mi­ty Assess­ment: Fol­low con­for­mi­ty assess­ment pro­ce­dures based on the clas­si­fi­ca­tion of the device
Gen­er­al Safe­ty and Per­for­mance Require­ments (GSPRs): Ensure that the app meets the GSPRs out­lined in the MDR. Require­ments cov­er aspects such as safe­ty, per­for­mance, risk man­age­ment, and usability.
Com­pli­ance with Health Care AI Reg­u­la­tions: Ensure that HealPlay’s AI and 3D Body Pose tech­nol­o­gy com­ply with health care AI laws and regulations
Lia­bil­i­ty and Risk Man­age­ment: Estab­lish clear terms of use and pri­va­cy poli­cies to man­age lia­bil­i­ty risks
Patent Search and Fil­ing: Con­duct a thor­ough search for exist­ing patents in the realms of AI, 3D body pose, and mobile sen­sor tech­nol­o­gy to ensure HealPlay’s prod­ucts do not infringe on exist­ing IP
Com­pli­ance and Data Pri­va­cy: Ensure com­pli­ance with inter­na­tion­al stan­dards and reg­u­la­tions for med­ical devices and data pro­tec­tion, such as GDPR and patient data act in Europe, to avoid legal pit­falls and build trust with users (*CE mark­ing above).
Posi­tion HealPlay as a pio­neer in the inte­gra­tion of AI and 3D Body Pose tech­nol­o­gy in physiotherapy.
Hire: Head of Prod­uct Devel­op­ment: To over­see the patient and HCP app development.
- Devel­op a unique val­ue propo­si­tion that high­lights HealPlay’s inno­v­a­tive approach to remote physiotherapy.
- Iden­ti­fy and pitch to angel investors and ven­ture cap­i­tal­ists spe­cial­iz­ing in health­care and tech­nol­o­gy startups.
Con­duct ini­tial train­ing sessions
Assign first project tasks to team members
Con­tin­ue Feed­back and CICD on cur­rent MVP build APP and sync with new UI
Nov
Tech­ni­cal Doc­u­men­ta­tion: Pre­pare tech­ni­cal doc­u­men­ta­tion that demon­strates the app’s com­pli­ance with the rel­e­vant requirements.
Com­pli­ance with Health Care AI Reg­u­la­tions: Pre­pare tech­ni­cal doc­u­men­ta­tions that demon­strates the app’s com­pli­ance with the rel­e­vant requirements.
File for patent to pro­tect the unique aspects of the patient and health­care pro­fes­sion­al app, par­tic­u­lar­ly the algo­rithms and process­es that enable the inte­gra­tion of these technologies
Phase 2: Aware­ness and Edu­ca­tion: — Launch an edu­ca­tion­al cam­paign to inform health­care pro­fes­sion­als and patients about the ben­e­fits of dig­i­tal physiotherapy.
- Uti­lize social media, webi­na­rs, and part­ner­ships with med­ical insti­tu­tions to spread awareness.
Hire CFO: Skilled in start­up finance, fundrais­ing, and bud­get management.
- For­mu­late strate­gic part­ner­ships with health­care providers and insti­tu­tions for pilot programs.
- Devel­op edu­ca­tion­al mate­ri­als and case stud­ies to demon­strate the ben­e­fits and effec­tive­ness of HealPlay.
- Iden­ti­fy and pitch to angel investors and ven­ture cap­i­tal­ists spe­cial­iz­ing in health­care and tech­nol­o­gy startups.
Start devel­op­ment on first major feature
Hold bi-week­ly progress meetings
Con­tin­ue Feed­back and CICD on cur­rent MVP build APP and sync with new UI
Dec
Tech­ni­cal Doc­u­men­ta­tion: Continued
Pro­fes­sion­al Stan­dards and Ethics: Align with pro­fes­sion­al eth­i­cal stan­dards for phys­io­ther­a­py, ensur­ing that the dig­i­tal ser­vices pro­vid­ed meet the indus­try’s codes of con­duct and practice.
Con­sid­er insur­ance to cov­er poten­tial legal claims
Trade Secret Poli­cies: Imple­ment poli­cies to pro­tect trade secrets, espe­cial­ly con­cern­ing the pro­pri­etary algo­rithms and data ana­lyt­ics meth­ods. This includes con­fi­den­tial­i­ty agree­ments with employ­ees and partners.
Copy­rights: File for copy­rights on the soft­ware code, user inter­face designs, and any orig­i­nal con­tent pro­vid­ed with­in the apps to pre­vent unau­tho­rized copy­ing or distribution.
Phase 3: Engage­ment and Com­mu­ni­ty Build­ing — Cre­ate an online com­mu­ni­ty for users to share their expe­ri­ences and progress.
- Engage with health­care pro­fes­sion­als through work­shops and sem­i­nars to fos­ter a com­mu­ni­ty around the HealPlay product.
Phase 2: Expan­sion of Tech­ni­cal Team — AI Engi­neers: To refine the AI algo­rithms and inte­grate new features.
Phase 2: Prod­uct Devel­op­ment and Test­ing — Final­ize the devel­op­ment of the patient and health­care pro­fes­sion­al app with a focus on user expe­ri­ence and tech­no­log­i­cal robustness.
- Launch new beta test­ing with select user groups to gath­er data and refine the prod­uct based on feed­back (find from the online engage­ment com­mu­ni­ty and HCP through our work­shops and seminars).
- Imple­ment AI adap­tive algo­rithms and improve 3D Body Pose tech­nol­o­gy to ensure accu­rate exer­cise guid­ance and feedback.
- Iden­ti­fy and pitch to angel investors and ven­ture cap­i­tal­ists spe­cial­iz­ing in health­care and tech­nol­o­gy startups.
Con­tin­ue fea­ture development
Begin inter­nal test­ing phase
2025
Jan
Clin­i­cal Eval­u­a­tion (*5 — 12 months): Con­duct a clin­i­cal eval­u­a­tion to demon­strate the app’s safe­ty and per­for­mance. This may involve clin­i­cal tri­als, lit­er­a­ture reviews, and oth­er forms of evi­dence to sup­port the app’s intend­ed use
Con­tin­u­ous Mon­i­tor­ing and Updat­ing: Reg­u­lar­ly mon­i­tor legal and reg­u­la­to­ry devel­op­ments in AI health care to ensure ongo­ing com­pli­ance and adapt the roadmap as necessary
Licens­ing Agree­ments: Devel­op licens­ing agree­ments for third-par­ty use of HealPlay’s tech­nol­o­gy, which can pro­vide an addi­tion­al rev­enue stream while con­trol­ling how the tech­nol­o­gy is used commercially
IP Port­fo­lio Man­age­ment: Reg­u­lar­ly review and man­age the IP port­fo­lio to keep up with tech­no­log­i­cal advance­ments and mar­ket trends, ensur­ing ongo­ing rel­e­vance and pro­tec­tion of HealPlay’s innovations
CRO orga­ni­za­tion: Clin­i­cal study (*12 months) regard­ing: — Reduced pain (60%) — reduced depres­sion and anx­i­ety (50%) — reduced need for surgery and med­ica­tion (50%) — Increased pro­duc­tiv­i­ty and reduced sick leave (40%) — Increased qual­i­ty of life (40%) Total of 800 000 SEK
Phase 4: Con­tent Mar­ket­ing — Devel­op a con­tent strat­e­gy that includes arti­cles, case stud­ies, and tes­ti­mo­ni­al videos high­light­ing the suc­cess sto­ries and data-backed results.
- Lever­age SEO to improve online vis­i­bil­i­ty and attract organ­ic traffic.
Hire: Mobile Devel­op­ers: For con­tin­u­ous devel­op­ment of the iOS and Android apps.
4x Devel­op­ers 36000 SEK/​month = 144 000 SEK
Hire: Data Ana­lysts: To han­dle the vast data from app usage and pro­vide insights.
Phase 3: Mar­ket­ing and Pre-Launch Activ­i­ties — Cre­ate a mul­ti-chan­nel mar­ket­ing plan that includes dig­i­tal mar­ket­ing, con­tent cre­ation, and tar­get­ed advertising.
- Engage with phys­io­ther­a­py com­mu­ni­ties and forums to build antic­i­pa­tion and gath­er ear­ly adopters.
- Lever­age social proof and tes­ti­mo­ni­als (videos) from ear­ly adopters to build cred­i­bil­i­ty and trust.
Phase 2: Series A Fund­ing — Objec­tive: Expand mar­ket reach and begin scal­ing oper­a­tions after val­i­dat­ing the prod­uct-mar­ket fit.
- Uti­lize data and tes­ti­mo­ni­als from pilot pro­grams to demon­strate effi­ca­cy and mar­ket demand.
Con­tin­ue fea­ture development
Con­tin­ue inter­nal test­ing phase
Feb
Clin­i­cal Evaluation
Stake­hold­er Engage­ment: Engage with legal experts, health care providers, and patients to gath­er insights and feed­back on the legal and reg­u­la­to­ry aspects of the service
IP Enforce­ment Plan: Estab­lish an enforce­ment plan to address poten­tial infringe­ment cas­es, which includes mon­i­tor­ing the mar­ket and tak­ing legal action when nec­es­sary to defend HealPlay’s IP rights.
CRO orga­ni­za­tion: Clin­i­cal study (*12 months) regard­ing: — Reduced pain (60%) — reduced depres­sion and anx­i­ety (50%) — reduced need for surgery and med­ica­tion (50%) — Increased pro­duc­tiv­i­ty and reduced sick leave (40%) — Increased qual­i­ty of life (40%) Total of 800 000 SEK
Phase 5: Pub­lic Rela­tions — Craft press releas­es to announce mile­stones (clin­i­cal study start­ed as med­ical claim), B2B part­ner­ships, and user suc­cess stories.
- Tar­get indus­try-spe­cif­ic pub­li­ca­tions and events to gain media coverage.
Phase 3: Growth and Diver­si­fi­ca­tion, hire: — Mar­ket­ing Direc­tor: To build brand aware­ness and dri­ve user acqui­si­tion. — Sales Man­ag­er: To estab­lish part­ner­ships with health­care providers. — Cus­tomer Sup­port Team: To assist users and gath­er feed­back for improve­ments. — Legal Advi­sor: To nav­i­gate the health­care indus­try’s reg­u­la­to­ry landscape.
Phase 4: Offi­cial Prod­uct Launch — Offi­cial­ly launch HealPlay with a strong online pres­ence and through health­care networks.
- Exe­cute the launch plan with a focus on dig­i­tal mar­ket­ing cam­paigns to reach a broad audience.
- Offer intro­duc­to­ry pro­mo­tions and incen­tives to encour­age sign-ups and app downloads.
- Mon­i­tor user feed­back and app per­for­mance close­ly to ensure a smooth rollout.
- Engage with larg­er ven­ture cap­i­tal firms and health­care-focused invest­ment funds.
- Con­sid­er strate­gic part­ner­ships with health­care insti­tu­tions for joint devel­op­ment and research opportunities.
Apply for EU fund­ing (as a joint con­sor­tium, espe­cial­ly when clin­i­cal study is ongoing)
Address feed­back from inter­nal testing
Pre­pare for first major fea­ture update release
Clin­i­cal Evaluation
CRO orga­ni­za­tion: Clin­i­cal study (*12 months) regard­ing: — Reduced pain (60%) — reduced depres­sion and anx­i­ety (50%) — reduced need for surgery and med­ica­tion (50%) — Increased pro­duc­tiv­i­ty and reduced sick leave (40%) — Increased qual­i­ty of life (40%) Total of 800 000 SEK
CRM/​Hubspot (30 000 SEK/​month)
Phase 6: User Acqui­si­tion and Reten­tion — Imple­ment refer­ral pro­grams and part­ner­ships with health­care providers to encour­age adoption.
- Offer com­pre­hen­sive sup­port and con­tin­u­ous updates to retain users and main­tain a high stan­dard of service.
Phase 4: Scal­ing and Opti­miza­tion: — HR Man­ag­er: To man­age the grow­ing team and fos­ter com­pa­ny cul­ture. — Busi­ness Devel­op­ment: To explore new mar­kets and strate­gic oppor­tu­ni­ties. — Qual­i­ty Assur­ance: To main­tain the high­est stan­dards in app per­for­mance. — Admin­is­tra­tive Staff: To sup­port the oper­a­tional needs of a scal­ing business.
QA Man­ag­er = 30 000 SEK/​month
Reg­u­la­to­ry Man­ag­er = 36 000 SEK/​month
Admin (ser­vice desk and cus­tomer sup­port) = 26 000 SEK
Sales Chan­nel Devel­op­ment — Iden­ti­fy and estab­lish key sales chan­nels, includ­ing direct online sales, part­ner­ships with clin­ics, and health­care platforms.
- Offer train­ing and sup­port for health­care pro­fes­sion­als to become pro­fi­cient in using the HealPlay platform.
Qual­i­ty assur­ance from Aspia (6000 SEK/2025)
Release first major fea­ture update
Gath­er user feed­back and mon­i­tor performance
Plan next fea­ture devel­op­ment based on feedback
Clin­i­cal Evaluation
CRO orga­ni­za­tion: Clin­i­cal study (*12 months) regard­ing: — Reduced pain (60%) — reduced depres­sion and anx­i­ety (50%) — reduced need for surgery and med­ica­tion (50%) — Increased pro­duc­tiv­i­ty and reduced sick leave (40%) — Increased qual­i­ty of life (40%) Total of 800 000 SEK
Phase 7: Data Uti­liza­tion and Feed­back Loop — Reg­u­lar­ly ana­lyze user data to improve the prod­uct and tai­lor mar­ket­ing strategies.
- Estab­lish a feed­back loop with users to ensure the prod­uct meets their evolv­ing needs.
Through­out these phas­es, HealPlay should pri­or­i­tize hir­ing indi­vid­u­als who share the com­pa­ny’s vision for rev­o­lu­tion­iz­ing phys­io­ther­a­py through technology.
The roadmap is flex­i­ble and should evolve with the com­pa­ny’s growth and the chang­ing land­scape of health­care technology.
The ulti­mate goal is to build a diverse, skilled team capa­ble of deliv­er­ing a cut­ting-edge solu­tion to mod­ern­ize phys­io­ther­a­py practices.
Phase 5: Cus­tomer Engage­ment and Reten­tion — Imple­ment feed­back mech­a­nisms with­in the app to gath­er user expe­ri­ences and improve the product.
- Intro­duce loy­al­ty pro­grams and refer­ral incen­tives to encour­age word-of-mouth promotion.
- Ana­lyze data col­lect­ed from users to refine and enhance the app’s fea­tures and user experience.
Sus­tain­able Rev­enue Streams — Sub­scrip­tion mod­el for the patient app with tiered services.
Qual­i­ty assur­ance from Aspia (6000 SEK/2025)
Con­tin­ue devel­op­ment of new features
Imple­ment user feed­back into exist­ing features
Reg­u­lar progress reviews and team assessments
Post-Mar­ket Sur­veil­lance (PMS): Imple­ment a PMS sys­tem to mon­i­tor the app’s per­for­mance and safe­ty on the mar­ket. This includes col­lect­ing and ana­lyz­ing data on adverse events, user feed­back, and oth­er rel­e­vant information
Unique Device Iden­ti­fi­ca­tion (UDI): Assign a UDI to the app to ensure trace­abil­i­ty and iden­ti­fi­ca­tion through­out its lifecycle
CRO orga­ni­za­tion: Clin­i­cal study (*12 months) regard­ing: — Reduced pain (60%) — reduced depres­sion and anx­i­ety (50%) — reduced need for surgery and med­ica­tion (50%) — Increased pro­duc­tiv­i­ty and reduced sick leave (40%) — Increased qual­i­ty of life (40%) Total of 800 000 SEK
Phase 8: Expan­sion and Scal­ing — Explore oppor­tu­ni­ties for col­lab­o­ra­tion with insur­ance com­pa­nies and health tech firms.
- Plan for geo­graph­ic expan­sion by under­stand­ing region­al reg­u­la­to­ry require­ments and mar­ket needs.
Phase 6: Expan­sion and Growth: Explore oppor­tu­ni­ties for inter­na­tion­al expan­sion and adapt the prod­uct to meet local reg­u­la­tions and mar­ket preferences.
Phase 3: Series B Fund­ing and Beyond — Objec­tive: Achieve wide­spread adop­tion and begin inter­na­tion­al expansion.
- Tar­get investors with a track record of scal­ing health­care tech­nol­o­gy companies.
- Lever­age suc­cess sto­ries and case stud­ies to attract late-stage investors and poten­tial acquirers.
Cost Man­age­ment and Allo­ca­tion: Invest in legal and reg­u­la­to­ry com­pli­ance to nav­i­gate the com­plex inter­na­tion­al health­care landscape.
Qual­i­ty assur­ance from Aspia (6000 SEK/2025)
Mid-year per­for­mance review
Adjust devel­op­ment plans based on performance
Ongo­ing fea­ture updates and improvements
Dec­la­ra­tion of Con­for­mi­ty: Issue a Dec­la­ra­tion of Con­for­mi­ty stat­ing that the app meets the applic­a­ble require­ments of the MDR
Affix CE Mark­ing: Affix the CE mark­ing to the app and ensure it is vis­i­ble and legible
Lan­guage Require­ments: Ensure that the app’s infor­ma­tion and instruc­tions are pro­vid­ed in the offi­cial lan­guages of the coun­tries where the app will be marketed
Phase 9: Sus­tain­abil­i­ty and CSR — High­light the envi­ron­men­tal ben­e­fits of remote phys­io­ther­a­py in mar­ket­ing materials.
- Ini­ti­ate cor­po­rate social respon­si­bil­i­ty (CSR) pro­grams that align with HealPlay’s mis­sion to reduce car­bon emissions.
Phase 7: Con­tin­u­ous Improve­ment and Inno­va­tion — Invest in ongo­ing research and devel­op­ment to keep the prod­uct at the fore­front of technology.
- Reg­u­lar­ly update the app with new fea­tures and improve­ments based on user feed­back and tech­no­log­i­cal advancements.
- Expand the investor search to include inter­na­tion­al ven­ture cap­i­tal firms.
Con­duct end-of-year review and plan­ning session
Set goals for the upcom­ing year
Ongo­ing fea­ture devel­op­ment and testing
2026
Risk Man­age­ment: Imple­ment risk man­age­ment process in accor­dance with ISO 14971 to iden­ti­fy, eval­u­ate, and mit­i­gate risks asso­ci­at­ed with the app
Phase 10: Con­tin­u­ous Inno­va­tion — Stay ahead of indus­try trends and con­tin­u­ous­ly inte­grate new tech­nolo­gies and features.
- Encour­age a cul­ture of inno­va­tion with­in the com­pa­ny to fos­ter new ideas and improvements.
This roadmap was designed to strate­gi­cal­ly intro­duce HealPlay to the mar­ket, build a strong cus­tomer base, and estab­lish the brand as a leader in mod­ern­ized phys­io­ther­a­py solutions.
By fol­low­ing this plan, HealPlay can set a new stan­dard in health­care deliv­ery and patient engagement.
- Licens­ing mod­el for health­care insti­tu­tions. — Data ana­lyt­ics ser­vices pro­vid­ing insights into patient progress and outcomes.
Release new fea­tures quarterly
Gath­er and imple­ment user feed­back continuously
Reg­u­lar team per­for­mance evaluations
- Allo­cate con­tin­ued funds for mar­ket­ing to increase brand aware­ness and user acquisition.
- Pri­or­i­tize R&D to con­tin­u­ous­ly improve the AI and 3D Body Pose tech­nol­o­gy and precision.
Focus on improv­ing exist­ing features
Begin plan­ning for major fea­ture releases
Ongo­ing team devel­op­ment activities
Finalise plans for major fea­ture releases
Con­duct thor­ough test­ing of new features
Reg­u­lar team and project progress reviews
Scale devel­op­ment efforts
Imple­ment advanced fea­tures and innovations
Annu­al per­for­mance reviews and strate­gic planning
2027
Exit Strat­e­gy: — Pre­pare for poten­tial acqui­si­tion by a B2B busi­ness part­ner (health­care or tech­nol­o­gy company).
Focus on fea­ture refine­ment and optimisation
Ensure high user sat­is­fac­tion and engagement
Annu­al per­for­mance reviews and strate­gic planning
2028
Exit Strat­e­gy: — Pre­pare for poten­tial acqui­si­tion by a larg­er health­care or tech­nol­o­gy company.
Exit Strat­e­gy: — Explore the pos­si­bil­i­ty of an ini­tial pub­lic offer­ing (IPO) as the com­pa­ny matures.
Con­duct per­for­mance review
Secure high user reten­tion and satisfaction
Pre­pare for exit strat­e­gy and poten­tial acquisition
2029
Con­clu­sion: HealPlay’s finance and fundrais­ing roadmap is designed to sup­port the com­pa­ny’s ambi­tious goals to trans­form physiotherapy.
By secur­ing the nec­es­sary fund­ing at each stage of growth, HealPlay can con­tin­ue to inno­vate and pro­vide val­ue to patients and health­care pro­fes­sion­als worldwide.
The roadmap bal­ances aggres­sive growth with pru­dent finan­cial man­age­ment, ensur­ing HealPlay’s long-term suc­cess and impact on the health­care industry.
Con­duct final per­for­mance review
Secure high user reten­tion and satisfaction
Finalise exit strat­e­gy and tran­si­tion plan

Financial Forecast

In order to be able to present an investment offer, we have made a financial prognosis from Start of plan to the year we plan for our now coming investors to exit their investment. This is to ascertain the ”total capital requirement” - in other words, how much capital we need to fund our company's entire Strategic roadmap.

We have made assumptions for both costs and revenue for our Normal Case to illustrate the cash flow and need for capital over time. This also gives us an idea of how much time it takes to become cash flow positive, hence the runway we need to finance with external capital.

Total capital need to finance the plan

SEK 4 889 273

Runway to become cash flow positive

33

No diagram has been uploaded or made public yet.
No forecasts has been uploaded or made public yet.

Financial Goals

Our financial goals by the year we plan for our now coming investors to exit their investment are shown below.

Revenue goal 2029

SEK 396 690 047

Profit goal 2029

SEK 218 771 478

ARR goal 2029

SEK 156 393 200

Yearly growth goal

314.00%


Potential Exit For Investor

All early stage investors need to plan for they are going to sell the shares with a profit. We have made investigations and have a few ideas on how our now coming investors potentially can exit this investment.

Description of Exit Strategy for the Investor

HealPlay presents several promising exit strategies, ensuring a lucrative return for investors.

1. Buyout by KRY:

- Strategic Fit: KRY, a leading telehealth provider, has expressed interest in integrating HealPlay's advanced physiotherapy solutions into their existing platform. The previous Director of Product at KRY Sweden, Hoa Ly, has highlighted the potential synergy, emphasizing how HealPlay’s capabilities can enhance KRY’s offerings.

- Integration Potential: The ease of integrating HealPlay’s products with KRY’s patient platform and demonstrating future traction will be critical. Given KRY’s robust patient base and market presence, this buyout would not only ensure seamless integration but also amplify HealPlay’s reach and impact.

2. Acquisition by B2B Partner or Competitor:

- Value Addition: Another viable exit strategy is a buyout from a B2B partner company or a competitor. Companies that provide solutions for specific patient groups, including exercise and nutrition tips, can significantly benefit from HealPlay’s real-time data, live feedback on exercise movements, and gamification features.

- Enhanced Proposition: By incorporating HealPlay’s technology, these companies can offer a superior joint value proposition to their patients, enhancing patient outcomes and engagement.

3. Industry Precedents:

- Comparable Acquisitions: The digital health market has seen significant acquisition activity, exemplified by Physitrack’s acquisition of Champion Health for £2.5M on May 9, 2022. Such transactions underscore the high value and demand for innovative health tech solutions like HealPlay’s.

Conclusion:

HealPlay’s exit strategy is anchored in potential buyouts by strategic partners such as KRY or industry competitors. These scenarios leverage HealPlay’s technological innovation and market fit, promising substantial returns for investors.

We have compared our future company with other similar companies that have done the kind of exit strategy we foresee to understand how such companies are valued. We have also found market reports from our industry that’s describes what valuations models are used and we have seen that companies like ours often are valued by applying a multiple on one or more key financial figures like revenue, profit or ARR.

When we use an average multiple and apply it on our future goals that gives us a fictitious valuation of our company.

Valuation at Exit for HealPlay

In assessing the potential exit valuation for HealPlay, we draw insights from the valuations and trajectories of comparable companies in the digital health and physiotherapy sector. Two notable competitors are Physitrack and Joint Academy.

Physitrack:

- Number of Funding Rounds: 4

- Total Funding Amount: $3.5M

Joint Academy:

- Joint Academy's valuation and funding details can also provide a relevant benchmark.

Key Factors Supporting HealPlay's Valuation:

1. Market Demand and Growth:

- The digital health market, especially in remote physiotherapy and rehabilitation, is expanding rapidly. With increasing adoption of telehealth and AI-driven solutions, HealPlay is well-positioned to capture a significant market share.

2. Innovative Technology:

- HealPlay’s advanced AI and machine learning capabilities, particularly in 3D body pose analysis and real-time feedback, provide a competitive edge. This technological innovation is a critical driver of our valuation, setting us apart from traditional and even some digital competitors.

3. Comprehensive Solution:

- Our platform offers a complete solution, from secure telehealth integration to a robust library of exercises validated by physiotherapists. This comprehensive approach increases user engagement and satisfaction, leading to higher retention rates and long-term revenue.

4. Scalability:

- HealPlay’s business model is inherently scalable. With the ability to expand geographically and into new markets and new business areas (for example fitness and mental health), our potential for growth is substantial. We plan to leverage this scalability to drive revenue and increase our valuation.

5. Funding and Financial Trajectory:

- Given the successful funding rounds of competitors like Physitrack, HealPlay is targeting similar or higher funding milestones. Our current financial trajectory, combined with anticipated funding, supports a robust valuation at exit.

6. Strategic Partnerships:

- We plan to establish strategic partnerships with healthcare providers and physiotherapy clinics, which will enhance our market presence and credibility. These partnerships are crucial for scaling our operations and increasing our market valuation.

Comparative Analysis:

- Physitrack’s Valuation:

- Physitrack, provides a benchmark. Given our technological advancements and comprehensive care model, HealPlay has the potential to achieve a similar or higher valuation (and also an IPO exit like Physitrack has done).

Conclusion:

We anticipate that our valuation at exit will be competitive with, if not exceed, the valuations achieved by our industry peers, reflecting the unique value and impact of HealPlay in the digital health and physiotherapy market.

Our financial goals and Valuation multiple:

  • Revenue x 2

  • Profit x 1

Fictitious valuation at 2029

SEK 506 075 786


Investment Proposal

Based upon our Normal case plan and goals we have made a financial design for the external capital necessary to cover the accumulated negative cash flow in our financial prognosis. The plan also covers the external equity we plan for and how much capital we plan to raise and their pre money valuations. We have done this in order to for-see the dilution effects for us as founders and our coming investors. Investors are taking their pro rata in the following round in our plan. Based upon our fictitious valuation we can also make assumptions of what potential return an investment would give for investors. This is our financing design:

Shares at present

Founders'

90

Passive

7

Pool for future Employees

3

Loan
Grants
Equity
Pre Money
Shares Issued
Total # Shares
Founders Owner %
External Owner %
Employees Owner % (Fully Diluted)
Investor 1
Round investment
Share
Return times investment
Avarage Annual Return (CAGR)
Total return at exit
Investor 2
Round investment
Share
Return times investment
Avarage Annual Return (CAGR)
Total return at exit

Our future owners

We hope to share our company with owners who believe in our vision, goals and us as a team. We have a strong plan for how to use external owners capital in order to build a growing and valuable company. To execute according to plan we think our future owners can contribute and these are our thoughts and questions to future owners.

How future owners can contribute:

Invests in Health Tech, AI/deep tech, promotes inclusion and diversity, previous founder knowledge is a plus, have a big network within/in health care and or clinical R&D. Can open doors, have marketing, sales, PR and scaling resources (remote consultant connections).

Questions to future owners

  • We are interested in understanding your expertise in health tech, which other health tech companies have you invested in?

  • What requirements do you have on your portfolio companies?

  • What ticket size do you usually invest in each company and how much share capital do you usually want? Please tell me more

  • In what phases/rounds do you invest in?

  • What similar investments have you done and how did it go? Both cases that was successful and those where things didn't go as planned.

  • Can you introduce us to founders you have worked with before?

  • Did you back the companies in more than one round?

  • Did you contribute with more than money?

  • How did you as an investor act when things went south for previous founders/company?

  • Do you accept convertible notes?

  • Can you tell us how you can promote, coach and help your portfolio companies to the next step?

  • What main skills and network do you have?

  • Will you be able to take lead in the next investment round and have you done this before successfully?

  • What is the next step?

  • Does your company have a team working for you?

  • Why would we as a company be a good fit for you?


Next step

Would you be interested in more information we would appreciate if you would sign our suggestion for an NDA. If you want to schedule a meeting please contact us.

Suggested ticket size

SEK 300 000

Time for next capital round

September 2024


About this report

We have concluded The Investment Readiness Process by Beels® [IRP] to prepare for our future growth and financial needs. We have been trained and supervised by Hannes Helander who is an IRP Certified Instructor. The IRP consist of five instructor led meetings and eight assignments. The result of those assignment are summarized in this IRP Report for an effective filtering and partial due diligence for an investor.

The Investment Readiness Process by Beels was created 2018 by Björn Larsson, entrepreneur and investor and Bjorn was inspired by Lennart Ohlsson (Swedish Angel Investor and author of ”Träffsäkra investeringar i startups”) and Jason Calacanis (US Angel Investor and author of the book "Angel - How to Invest in Technology Startups--Timeless Advice from an Angel Investor Who Turned $100,000 Into $100,000,000”.


The Investment Readiness Process was conducted by the Certified IRP Instructor: